LifeSci Capital Downgrades Mineralys Therapeutics, Inc. (MLYS) to Outperform
Tweet Send to a Friend
LifeSci Capital analyst Rami Katkhuda downgraded Mineralys Therapeutics, Inc. (NASDAQ: MLYS) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
